Welcome to our dedicated page for Marex Group plc SEC filings (Ticker: MRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles U.S. Securities and Exchange Commission filings for Marex Group plc (NASDAQ: MRX), a diversified global financial services platform operating across energy, commodities and financial markets. As a foreign private issuer, Marex files an annual report on Form 20-F and periodic Form 6-K reports that furnish press releases and financial information to U.S. investors.
Recent Form 6-K filings include earnings-related disclosures, such as interim results, third quarter results and preliminary trading updates. These documents provide detail on revenue, adjusted profit before tax, segment performance across Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions, as well as information on net commission income, net trading income, net interest income and net physical commodities income. They also discuss non-IFRS measures, their definitions and reconciliations to the most comparable IFRS metrics.
Other 6-Ks relate to corporate actions and governance, including press releases about purchases of ordinary shares by the Chief Executive Officer and other directors and officers. These filings help investors track insider share dealings and understand how management and board members are building or adjusting their holdings in Marex.
Filings may also reference capital and ratings developments, such as senior debt issuances, Additional Tier 1 instruments and credit ratings from S&P Global Ratings for Marex Group and its U.S. subsidiary, Marex Capital Markets Inc. Together, these disclosures provide insight into the Group’s capital structure, funding and external credit assessment.
On Stock Titan, Marex’s SEC filings are updated as new documents are released on EDGAR. AI-powered tools can assist users by surfacing key points from lengthy filings, highlighting segment trends, explaining non-IFRS measures and drawing attention to notable items such as insider transactions and earnings commentary, helping readers navigate the technical language common in cross-border capital markets reporting.
A shareholder of MRX has filed a notice of proposed sale of 57,709 shares of common stock, to be sold through Goldman Sachs & Co. LLC, with an approximate sale date of January 7, 2026 on the NASD market. The issuer had 71,231,706 shares of common stock outstanding at the time referenced. The shares to be sold were acquired mainly as restricted stock unit compensation from the issuer between 2021 and 2024, along with shares bought directly from the issuer in private and public transactions.
During the three months before this notice, Thomas Hugues Texier sold 4,285 shares of common stock on each of October 6, 2025, November 3, 2025, and December 1, 2025, for gross proceeds of $126,060.60, $132,468.83, and $150,659.49, respectively.
Marex Group plc is offering leveraged barrier notes linked to the STOXX® Europe 600 Index. Each Note has a $1,000 principal amount, trades in book-entry form and is expected to mature on December 27, 2027, with the final index level observed on December 20, 2027. Application has been made to list the Notes on the Vienna MTF of the Vienna Stock Exchange.
At maturity, investors receive cash based on index performance. If the index return is positive, the payoff is $1,000 plus 151% of the positive return. If the index return is between 0% and the -15% barrier, investors receive only their $1,000 back. If the index return falls below the -15% barrier, the payoff is reduced one-for-one with the index loss, down to a possible total loss of principal. The Notes pay no periodic interest, are senior unsecured obligations of Marex and are subject to its credit risk. The Estimated Initial Value on the pricing date is expected to be between $940 and $980 per Note, lower than the price to the public.
Marex Group plc filed a Form 13F holdings report, detailing institutional equity positions managed by the firm. The filing lists 1,269 reportable entries with a combined Form 13F Information Table Value Total of $14,151,249,919. The report includes 4 other included managers, indicating multiple affiliated entities contributing to the consolidated disclosures.
Other included managers are identified as Marex Financial, MAREX CAPITAL MARKETS INC., Marex Securities Products Inc., and Marex Prime Services Ltd.
Marex Group plc has submitted a Form 6-K as a foreign private issuer to furnish its third quarter 2025 earnings information. The filing does not contain the financial results directly, but instead attaches the Company’s press release titled “Marex Group plc announces third quarter 2025 results” as Exhibit 99.1. Investors need to review this exhibit to see the detailed figures and commentary on the quarter’s performance.
Marex Group plc furnished a Form 6-K noting a company press release on insider share activity. On October 15, 2025, the company announced that its directors and officers purchased ordinary shares.
The press release is provided as Exhibit 99.1 titled “Marex announces share purchases by Directors and Officers.”
Marex Group plc filed a Form 6-K reporting that it furnished a press release titled “Marex announces purchase of shares by Chief Executive Officer.” The press release was issued on October 13, 2025.
The release is included as Exhibit 99.1. The filing was signed on the company’s behalf by Chief Financial Officer Robert Irvin on October 14, 2025.
Marex Group plc has submitted a report as a foreign private issuer that mainly serves to share a recent company announcement with U.S. investors. The company attaches a press release dated 8 October 2025 titled “Marex Group plc provides a strong preliminary Q3 trading update,” indicating management views third-quarter 2025 trading performance as strong, although no specific financial figures are included here. The press release is furnished as Exhibit 99.1, and the document is signed on behalf of the company by Chief Financial Officer Robert Irvin.
Marex Group plc (MRX) filed a Form 144 reporting a proposed sale of 56,000 common shares through Goldman Sachs & Co. LLC with an aggregate market value of $1,631,840. The filing shows approximately 71,231,706 shares outstanding and lists an approximate sale date of 10/06/2025. The shares were acquired on 04/29/2016 as restricted stock units paid as compensation. The filer previously sold three blocks of 14,000 shares each on 07/07/2025, 08/04/2025, and 09/02/2025 for gross proceeds of $545,115.20, $530,272.40, and $488,163.20, respectively. The notice includes the standard representation that the seller does not possess undisclosed material information and references Rule 10b5-1 trading-plan language.
Marex Group plc insider notice reports a proposed sale of 12,855 shares of common stock through Goldman Sachs & Co. LLC on 10/06/2025, with an aggregate market value of $374,594.70. The shares were originally acquired as restricted stock units on 12/21/2021 and were granted as compensation. The filer previously sold three blocks of 4,285 shares each on 07/07/2025, 08/04/2025, and 09/02/2025, generating gross proceeds of $166,832.19, $162,239.96, and $149,420.52 respectively. The notice includes the standard Rule 144 representation that the seller is not aware of undisclosed, material adverse information.
Marex Group plc filed a Form 13F reporting its institutional equity holdings. The filing lists 901 Form 13F information table entries with a total value of $11,529,406,132 and identifies 4 other included managers. The report was signed by Jae Cho, Director on 08-18-2025.